Review the side-effects of Acalabrutinib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Common: Diarrhea, headache, muscle ache, tiredness, bruising, bleeding
Gastrointestinal: Nausea, pain in the stomach, vomiting, constipation
Cardiovascular: Bleeding events, irregular heartbeat, atrial flutter or fibrillation
Blood: Reduced number of red blood cells, white blood cells or platelets
Skin: Rashes, bruises, skin cancer
Others: Nasal bleeding, increased level of creatinine in blood, serious infections including pneumonia and reactivation of hepatitis B infection, other cancers
• Do not take a double dose to make up the missed dose.
• Breastfeeding should de discontinued while on treatment with acalabrutinib and should not be resumed at least 2 weeks after the last dose of acalabrutinib.
• Patients are advised to report to the emergency center if serious reactions such as severe bleeding, serious infection or difficulty in breathing occur.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Common: Diarrhea, headache, muscle ache, tiredness, bruising, bleeding
Gastrointestinal: Nausea, pain in the stomach, vomiting, constipation
Cardiovascular: Bleeding events, irregular heartbeat, atrial flutter or fibrillation
Blood: Reduced number of red blood cells, white blood cells or platelets
Skin: Rashes, bruises, skin cancer
Others: Nasal bleeding, increased level of creatinine in blood, serious infections including pneumonia and reactivation of hepatitis B infection, other cancers
Other Precautions :
• If a dose is missed for more than three hours after the scheduled time, continue with next scheduled dose and skip the missed dose.• Do not take a double dose to make up the missed dose.
• Breastfeeding should de discontinued while on treatment with acalabrutinib and should not be resumed at least 2 weeks after the last dose of acalabrutinib.
• Patients are advised to report to the emergency center if serious reactions such as severe bleeding, serious infection or difficulty in breathing occur.
